GlaxoSmithKline Intellectual Property Development Limited
发明人:
Niall Andrew ANDERSON,Matthew Howard James CAMPBELL-CRAWFORD,Ashley Paul HANCOCK,Seble LEMMA,Simon John Fawcett MACDONALD,John Martin PRITCHARD,Panayiotis Alexandrou PROCOPIOU,Stephen SWANSON
申请号：
US15514414
公开号：
US20170290818A1
申请日:
2015.09.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A compound according to formula (I)wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups； or a pharmaceutically acceptable salt thereof.
